Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens.

Kodani M, Yang G, Conklin LM, Travis TC, Whitney CG, Anderson LJ, Schrag SJ, Taylor TH Jr, Beall BW, Breiman RF, Feikin DR, Njenga MK, Mayer LW, Oberste MS, Tondella ML, Winchell JM, Lindstrom SL, Erdman DD, Fields BS.

J Clin Microbiol. 2011 Jun;49(6):2175-82. doi: 10.1128/JCM.02270-10. Epub 2011 Apr 6.

2.

Healthcare utilization and cost of pneumococcal disease in the United States.

Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, Zell ER, Linder JA, Grijalva CG, Metlay JP, Finkelstein JA.

Vaccine. 2011 Apr 18;29(18):3398-412. doi: 10.1016/j.vaccine.2011.02.088. Epub 2011 Mar 11.

PMID:
21397721
3.

Effective management in clusters of pneumococcal disease: a systematic review.

Basarab M, Ihekweazu C, George R, Pebody R.

Lancet Infect Dis. 2011 Feb;11(2):119-30. doi: 10.1016/S1473-3099(10)70281-4. Review.

PMID:
21272792
5.

Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices.

MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6.

6.

Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes.

da Gloria Carvalho M, Pimenta FC, Jackson D, Roundtree A, Ahmad Y, Millar EV, O'Brien KL, Whitney CG, Cohen AL, Beall BW.

J Clin Microbiol. 2010 May;48(5):1611-8. doi: 10.1128/JCM.02243-09. Epub 2010 Mar 10.

7.

Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era.

Gertz RE Jr, Li Z, Pimenta FC, Jackson D, Juni BA, Lynfield R, Jorgensen JH, Carvalho Mda G, Beall BW; Active Bacterial Core Surveillance Team.

J Infect Dis. 2010 Mar;201(5):770-5.

PMID:
20178139
8.

Continued impact of pneumococcal conjugate vaccine on carriage in young children.

Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, Lipsitch M, Hanage WP, Lee GM, Finkelstein JA.

Pediatrics. 2009 Jul;124(1):e1-11. doi: 10.1542/peds.2008-3099.

9.

Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine.

Sá-Leão R, Nunes S, Brito-Avô A, Frazão N, Simões AS, Crisóstomo MI, Paulo AC, Saldanha J, Santos-Sanches I, de Lencastre H.

Clin Microbiol Infect. 2009 Nov;15(11):1002-7. doi: 10.1111/j.1469-0691.2009.02775.x. Epub 2009 Apr 23.

10.
11.

Respiratory viruses predisposing to bacterial infections: role of neuraminidase.

Peltola VT, McCullers JA.

Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S87-97. Review.

PMID:
14730275
12.

Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies.

O'Brien KL, Bronsdon MA, Dagan R, Yagupsky P, Janco J, Elliott J, Whitney CG, Yang YH, Robinson LG, Schwartz B, Carlone GM.

J Clin Microbiol. 2001 Mar;39(3):1021-4.

Supplemental Content

Support Center